Dementia update: Pharmacologic management of agitation and psychosis in older demented patients

Geriatrics

Volumn 58, Issue 10, 2003, Pages 48-53

  Zaraa, Adel S ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; VALPROIC ACID;

AGED; AGITATION; ALZHEIMER DISEASE; ANTICHOLINERGIC EFFECT; ATAXIA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FALLING; FOOD AND DRUG ADMINISTRATION; GAIT DISORDER; HUMAN; LIVER TOXICITY; ORTHOSTATIC HYPOTENSION; PSYCHOSIS; RATING SCALE; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; URINE RETENTION; VERTIGO; XEROSTOMIA;

AGED; ANTIPSYCHOTIC AGENTS; DEMENTIA; HUMANS; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS;

EID: 0141924735     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed). Washington, DC: American Psychiatric Association, 1994.
2. Finkel SI, Burns A, Cohen G. Behavioral and psychological symptoms of dementia: A clinical and research update. Overview. International Psychogeriatrics 2000; 12(supp 1): 13-8.
3. Rovner BW, Kafonek S, Filipp L, Lucas MJ, Folstein MF. Prevalence of mental illness in a community nursing home. Am J Psychiatry 1986; 143(11):1446-9.
4. Cohen-Mansfield J. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986; 34(10):722-7.
5. Ballard CG, Margallo-Lana M, Fossey J, et al. A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. J Clin Psychiatry 2001; 62(8):631-6.
6. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: Findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000; 157(5):708-14.
7. Alexopoulos GS, Silver JM, Kahn DA, Frances A, Carpenter D (eds). Treatment of agitation in older persons with dementia. Postgraduate medicine special report. Expert consensus guideline series. Minneapolis, Minnesota: McGraw-Hill Healthcare Information Programs, 1998.
8. Petty RG, Bonner D, Mouratoglou V, Silverman M. Acute frontal lobe syndrome and dyscontrol associated with bilateral caudate nucleus infarctions. Br J Psychiatry 1996; 168(2):237-40.
9. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000; 8(1):29-34.
10. Tariot PH, Blazina L. The psychopathology of dementia. In: Morris J (ed). Handbook of dementing illness. New York: Marcel Dekker, 1993:461-75.
11. Brodaty H, Draper B, Saab D, et al. Psychosis, depression, and behavioral disturbances in Sydney nursing home residents: Prevalence and predictors. Int J Geriatr Psychiatry 2001; 16(5):504-12.
12. Omnibus Reconciliation Act 1987. PP 100-203 December 22, 1987.
13. Borson S, Doane K. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv 1997; 48(10):1289-96.
14. American Psychiatric Association. Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997; 154(5 suppl):1-39.
15. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999; 60(2):107-15.
16. De Deyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999; 53(5):946-55.
17. Woodward M, Brodaty H, Ames D, et al. Risperidone in the treatment of agitation and psychosis of dementia. Presented at: First Annual Meeting of the International College of Geriatric Psychoneuropharmacology; December 14th-15th, 2001; Waikoloa, Hawaii.
18. Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000; 57(10):968-76.
19. McManus DQ, Arvanitis LA, Kowalcyk BB. Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry 1999; 60(5):292-8.
20. Targum SD, Arvantis LA. Quetiapine: Efficacy, safety, and tolerability in elderly subjects with psychotic disorders. Psychopharmacol Bull 1997; 33(3):595.
21. Defilippi JL, Crismon ML. Antipsychotic agents in patients with dementia. Pharmacotherapy 2000; 20(1):23-33.
22. Greenspan A. Risk of cerebrovascular adverse events, including mortality, with risperidone in elderly patients. Poster presented at: Eleventh Congress of the International Psychogeriatric Association: August 17-22, 2003: Chicago, IL.
23. 2003 Safety alert-Risperdal (risperidone). www.fda.gov/medwatch/SAFETY/2003/risperdal.htm. Accessed September 23, 2003.
24. Tariot PN, Erb R, Leibovici A, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: A preliminary study. J Am Geriatr Soc 1994; 42(11):1160-6.
25. Mellow AM, Solano-Lopez C, Davis S. Sodium valproate in the treatment of behavioral disturbance in dementia. J Geriatr Psychiatry Neurol 1993; 6(4):205-9.
26. Kunik ME, Yudofsky SC, Silver JM, Hales RE. Pharmacologic approach to management of agitation associated with dementia. J Clin Psychiatry 1994; 55(Suppl):13-7.
27. Gottfries CG, Nyth AL. Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia. Ann N Y Acad Sci 1991; 640:276-9.
28. Finkel SI, Mintzer JE, Dysken M, Krshnan KRR, Burt T, McRae TA. Randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry (Accepted).